Contract Manufacturing
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
16
NCT06963411
Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: May 9, 2025
Completion: Jul 18, 2025
Loading map...